MedTrace Logo

Investigational Study of the Ekso for High-Dosage Use by Individuals With SCI in a Non-Clinical Environment

NCT02566850 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2023-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to study the safety and health effects of using the Ekso Bionics powered exoskeleton device in a home setting over an extended period, ranging from 12-42 months.

Conditions

  • Spinal Cord Injuries

Interventions

DEVICE

Ekso

powered lower extremity exoskeleton

Sponsors & Collaborators

  • Ekso Bionics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2017-07-25
Completion
2017-07-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02566850 on ClinicalTrials.gov